Cva Family Office, LLC Merck & Co., Inc. Transaction History

Cva Family Office, LLC

$606 Million
Q3 2024

A detailed history of Cva Family Office, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Cva Family Office, LLC holds 10,603 shares of MRK stock, worth $1.09 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

10,603

Previous 10,672 0.65%

Holding current value

$1.09 Million

Previous $1.32 Million 8.86%

% of portfolio

0.2%

Previous 0.24%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	SELL	$111.15 - $128.97 $7,669 - $8,898	-69 Reduced 0.65%	10,603 $1.2 Million
Q2 2024 Jul 09, 2024	SELL	$123.8 - $132.96 $43,949 - $47,200	-355 Reduced 3.22%	10,672 $1.32 Million
Q1 2024 Apr 10, 2024	BUY	$113.24 - $131.95 $10,191 - $11,875	90 Added 0.82%	11,027 $1.46 Million
Q4 2023 Jan 16, 2024	SELL	$100.18 - $109.02 $13,424 - $14,608	-134 Reduced 1.21%	10,937 $1.19 Million
Q3 2023 Oct 11, 2023	BUY	$102.95 - $114.33 $617 - $685	6 Added 0.05%	11,071 $1.14 Million
Q2 2023 Jul 10, 2023	BUY	$108.61 - $118.38 $86,888 - $94,704	800 Added 7.79%	11,065 $1.28 Million
Q1 2023 Apr 26, 2023	SELL	$102.94 - $114.86 $5,352 - $5,972	-52 Reduced 0.5%	10,265 $1.09 Million
Q4 2022 Feb 21, 2023	BUY	$87.44 - $112.11 $31,390 - $40,247	359 Added 3.61%	10,317 $1.14 Million
Q3 2022 Nov 22, 2022	BUY	$84.53 - $94.96 $181,570 - $203,974	2,148 Added 27.5%	9,958 $858,000
Q2 2022 Jul 11, 2022	BUY	$83.49 - $94.64 $24,295 - $27,540	291 Added 3.87%	7,810 $712,000
Q1 2022 Apr 22, 2022	BUY	$73.51 - $82.4 $148,196 - $166,118	2,016 Added 36.63%	7,519 $617,000
Q4 2021 Jan 25, 2022	BUY	$72.28 - $90.54 $867 - $1,086	12 Added 0.22%	5,503 $422,000
Q3 2021 Oct 12, 2021	SELL	$71.68 - $78.83 $135,331 - $148,831	-1,888 Reduced 25.59%	5,491 $455,000
Q2 2021 Jul 13, 2021	BUY	$70.31 - $77.77 $58,146 - $64,315	827 Added 12.62%	7,379 $574,000
Q1 2021 Apr 14, 2021	BUY	$68.86 - $81.11 $65,623 - $77,297	953 Added 17.02%	6,552 $505,000
Q4 2020 Jan 15, 2021	BUY	$71.77 - $79.65 $7,751 - $8,602	108 Added 1.97%	5,599 $437,000
Q3 2020 Oct 27, 2020	BUY	$73.18 - $82.95 $48,371 - $54,829	661 Added 13.69%	5,491 $455,000
Q2 2020 Jul 31, 2020	BUY	$70.42 - $80.13 $34,928 - $39,744	496 Added 11.44%	4,830 $373,000
Q1 2020 May 28, 2020	BUY	$63.36 - $87.82 $28,068 - $38,904	443 Added 11.39%	4,334 $333,000
Q4 2019 Feb 18, 2020	BUY	$77.58 - $87.54 $301,863 - $340,618	3,891 New	3,891 $354,000

Others Institutions Holding MRK

# of Institutions

3,824

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cva Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cva Family Office, LLC with notifications on news.

Account

Cva Family Office, LLC Merck & Co., Inc. Transaction History